Category: Steris Corp.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: U.K. regulators OK $2B Steris merger with Synergy Health; Hospira beats earnings forecasts for Q4, 2014; U.K. regulators pass on probe of Zoll Medical's Philips InnerCool buy; William Demant in talks to buy French hearing aid retailer Audika
Zoll Medical Corp.
, Costco Wholesale Corp.
, Hospira Inc.
, Pfizer Inc.
, Royal Philips
, Sonova Holding AG
, Steris Corp.
, Synergy Health
, U.K. Competition and Markets Authority
, William Demant Holding
U.K. regulators approve the proposed $2 billion inversion merger between Steris and Synergy Health.
The U.S. Federal Trade Commission wants more information from Steris Corp. and Synergy Health on their proposed, $2 billion inversion merger.
An EPA advisory panel meeting that began today could disrupt medical device supply chains if the panel upholds the agency's classification of a ubiquitous sterilizer as carcinogenic.
A scientific advisory panel to the EPA is convening today to evalute the environmental watchdog's determination that a common medical device sterilizer, ethylene oxide, is carcinogenic.
If the panel confirms that assessment, medtech companies warn, it could disrupt the supply chain for their lifesaving products.
Sterigenics is put on the auction block by its private equity owners, who hope the contract sterilization company will fetch $1.5 billion.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic announces leadership roster for post-Covidien merger; Allergan raises outlook; says Valeant offer undervalues company; EuroZone anti-trust regulators to rule next month on $43B Covidien buy; Steris to buy UK's Synergy Health, tax savings eyed; Bioventus bolsters bone healing lineup
Steris agrees to a $1.9 billion buyout of U.K. sterilization services provider Synergy Health in the 1st inversion deal since a U.S. Treasury crackdown.